SCHEMBL5690244

SCHEMBL5690244

Cc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cccc(NC(=O)C3CCNCC3)c2)C(=O)O)cc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
ITGB1 P05556 5/20 0.55
ITGA5 P08648 3/20 0.55
HCRTR1 O43613 4/20 0.53
HCRTR2 O43614 4/20 0.53
ITGA4 P13612 3/20 0.52
ITGA2 P17301 1/20 0.51
MAPT P10636 3/20 0.50
POLB P06746 3/20 0.50
ITGAV P06756 1/20 0.50
FKBP1A P62942 1/20 0.49
KDM4E B2RXH2 1/20 0.48
TP53 P04637 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
MAPK1 P28482 2/20 0.48
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5691025 0.91 ITGB1 (0.63) ALDH1A1ITGB1ITGA5ITGA4ITGA2
SCHEMBL5694503 0.91 ITGB1 (0.50) ALDH1A1ITGB1ITGA5HCRTR1HCRTR2
SCHEMBL5690483 0.89 ITGB1 (0.53) ALDH1A1ITGB1ITGA5HCRTR1HCRTR2
SCHEMBL5690979 0.88 ALDH1A1 (0.53) ALDH1A1ITGB1ITGA5HCRTR1HCRTR2
SCHEMBL5692071 0.85 HCRTR1 (0.53) ALDH1A1ITGB1ITGA5HCRTR1HCRTR2
SCHEMBL6708314 0.84 ITGB1 (0.65) ALDH1A1ITGB1ITGA5ITGA4ITGA2
SCHEMBL7069740 0.84 ALDH1A1 (0.70) ALDH1A1ITGB1ITGA5ITGA4ITGA2
SCHEMBL7066469 0.84 ALDH1A1 (0.70) ALDH1A1ITGB1ITGA5ITGA4ITGA2
SCHEMBL6710892 0.84 ALDH1A1 (0.70) ALDH1A1ITGB1ITGA5ITGA4ITGA2
SCHEMBL27514023 0.84 ALDH1A1 (0.70) ALDH1A1ITGB1ITGA5ITGA4ITGA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001974-B1 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARM INC (US) 2006-05-24 EP claimed
US-6291453-B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 ATHENA NEUROSCIENCES, INC. 2001-09-18 US claimed
EP-1001974-A1 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006434-A1 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS INC. (US) 1999-02-11 WO claimed
EP-1001974-B1 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARM INC (US) 2006-05-24 EP disclosed
US-6291453-B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 ATHENA NEUROSCIENCES, INC. 2001-09-18 US disclosed
EP-1001974-A1 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006434-A1 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS INC. (US) 1999-02-11 WO disclosed